Mariner
VTYX

Mariner’s Ventyx Biosciences VTYX Stock Holding History

Mariner’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,468
Closed -$26.7K – 3774
2025
Q2 		$26.7K Sell
12,468
-4,387
-26% -$7.08K ﹤0.01% 3392
2025
Q1 		$19.4K Sell
16,855
-5,250
-24% -$9.01K ﹤0.01% 3382
2024
Q4 		$48.4K Sell
22,105
-8,485
-28% -$19.2K ﹤0.01% 3292
2024
Q3 		$66.7K Sell
30,590
-65,066
-68% -$150K ﹤0.01% 3156
2024
Q2 		$221K Sell
95,656
-20,608
-18% -$85.6K ﹤0.01% 2709
2024
Q1 		$639K Sell
116,264
-31,226
-21% -$143K ﹤0.01% 1848
2023
Q4 		$364K Buy
147,490
+140,362
+1,969% +$1.33M ﹤0.01% 2179
2023
Q3 		$248K Buy
+7,128
New +$246K ﹤0.01% 2328

Other funds holding VTYX

AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Mariner's VTYX Position: Q3 2025 in Review

Mariner sold out of Ventyx Biosciences (VTYX) in Q3 2025, closing a stake of 12,468 shares — an estimated $26.7K sold.

Mariner first reported a position in VTYX in Q3 2023 and held it in 8 quarters. The position peaked at $639K in Q1 2024. 110 funds tracked by Wall St. Rank hold VTYX as of Q3 2025.

  • Mariner reported no remaining Ventyx Biosciences position as of Q3 2025 after selling out during the quarter.
  • Mariner sold 12,468 Ventyx Biosciences shares in Q3 2025, an estimated $26.7K.
  • Mariner first reported a position in Ventyx Biosciences in Q3 2023 and held it in 8 quarters.
  • Mariner's Ventyx Biosciences position peaked at $639K in Q1 2024.
  • 110 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q3 2025.

Based on Mariner's 13F filing for Q3 2025, filed 14 Nov 2025.